Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]
1048A (2000400805)
Meningitis (in) Lyme disease
G01*A69.2 (2000502068)
Acrodermatitis chronica atrophicans
L90.4 (45533661)
Polyneuropathy (in) Lyme disease
G63.0*A69.2 (2000502178)
Erythema in other diseases classified elsewhere and Lyme disease
L54.8*A69.2 (2000504056)
Neurological infection other
N73 (2002000778)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 (2002330109)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
Lyme disease
A69.2 (45595594)
Arthritis in Lyme disease
M01.2*A69.2 (2000502987)
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
307 (2001600266)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING - SMOKE2: no - SMOKE3: Unspecified - SMOKE5: Unspecified
SMOKING-2-0-0 (2002330112)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
probenecid; oral
M04AB01 (21604136)
Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
27315-1 (3007695)
Lymphocytes/Leukocytes in Cerebral spinal fluid
26479-6 (3020951)
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
42507-4 (3031072)
Granulocytes/Leukocytes in Cerebral spinal fluid
33963-0 (3042847)
Oxygen content in Capillary blood by calculation
64799-0 (40767503)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Arthritis in Lyme disease
M01.2 (45567391)
Tick-borne viral encephalitis, unspecified
A84.9 (45571447)
Gas panel - Central venous blood
97535-9 (1616796)
Toothache NOS
K08.80 (2000502799)
Lumbar puncture
TAB00 (2001300538)
Stopping epidural fluid escape with coagulated blood
TAB22 (2001300541)
Cervical spine MRI examination with high intensity magnet
NA1BG (2001306990)
Spine and spinal cord very extensive MRI examination with high intensity magnet
NA7DG (2001307084)
Pelvic, hip and femur MRI examination with high intensity magnet
NE1BG (2001307800)
Noninvasive ventilation
WX725 (2001310828)
Diabetes, non-insulin-treated
215 (2001600211)
Removal of foreign body from under the skin
SPAT1152 (2001700253)
Screening procedure
SPAT1324 (2001700425)
Extensive global examination
SPAT1360 (2001700461)
Skin injury other
S19 (2002000984)
Scabies/other acariasis
S72 (2002001036)
Pediculosis/skin infestation other
S73 (2002001037)
Diabetes insulin dependent
T89 (2002001130)
potassium chloride; oral
A12BA01 (21600877)
risperidone; oral, parenteral
N05AX08 (21604559)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18243-6 (3002823)
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 (3007368)
IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
2470-3 (3007798)
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 (3009991)
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 (3010521)
FEV1/FVC
19926-5 (3011505)
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 (3012220)
Hantavirus puumala IgG Ab [Titer] in Serum
22308-1 (3012447)
Albumin in CSF/Albumin in Serum or Plasma
1756-6 (3013247)
Varicella zoster virus Ab [Titer] in Serum
21594-7 (3014148)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
Varicella zoster virus IgG Ab [Units/volume] in Serum
8047-3 (3022575)
FEV1 --post bronchodilation
20155-8 (3023550)
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 (3024474)
Herpes simplex virus Ab [Presence] in Serum
22339-6 (3028679)
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 (3033386)
Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
17303-9 (3035929)
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
42991-0 (3037677)
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
40729-6 (3041145)
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
44506-4 (3043525)
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
41150-4 (3044212)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33942-4 (3046896)
Cerebrospinal fluid IgG ratio and IgG index
1324000 (4027681)
Venereal disease screening
171128005 (4064905)
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 (40759883)
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
58755-0 (40761849)
Stomach Pathology biopsy report
66114-0 (40768797)
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69930-6 (42868421)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70058-3 (42868544)
Unspecified viral encephalitis
A86 (45542542)
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 (45552058)
Type 2 diabetes mellitus, with multiple complications
E11.7 (45561950)
Encephalitis, myelitis and encephalomyelitis, unspecified
G04.9 (45562073)
Congestive heart failure
I50.0 (45567179)
Bell palsy
G51.0 (45571815)
Erythematous condition, unspecified
L53.9 (45577042)
Tinea pedis
B35.3 (45581158)
Cellulitis of other parts of limb
L03.1 (45586760)
Other dermatitis
L30 (45591633)
Radiological examination, not elsewhere classified
Z01.6 (45605096)
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 (3008230)
amoxicillin; oral, parenteral
J01CA04 (21602823)
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 (3016888)
Insect bite/sting
S12 (2002000977)
Infectious Disease
44 (38004484)
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
W57 (45756308)
doxycycline; oral, parenteral
J01AA02 (21602800)
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 (3011166)
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 (3014973)
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 (3010380)
Skin symptom/complaint other
S29 (2002000993)
Taking care of patient’s/customer’s hygiene
SPAT1137 (2001700238)
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
74917-6 (44816808)
Differential panel - Cerebral spinal fluid
29584-0 (3016018)
Appearance of Cerebral spinal fluid
10333-3 (3023410)
Dermatitis, unspecified
L30.9 (45572271)
Animal/human bite
S13 (2002000978)
Medical doctor
Z2221 (2001311556)
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 (3019473)
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 (3020044)
Bilateral hand X-ray examination
ND2DA (2001307619)
Cell count panel - Cerebral spinal fluid
34563-7 (3044290)
Limited function/disability NOS
A28 (2002000162)
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
69923-1 (42868414)
encephalitis, tick borne, inactivated, whole virus
J07BA01 (21601331)
Fever, unspecified
R50.9 (45582716)
Bilateral foot X-ray examination
NH3DA (2001308279)
Biopsy of skin and subcutaneous tissue
TQX10 (2001310152)
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 (3027475)
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 (3016543)
colecalciferol; oral
A11CC05 (21600820)
Headache
R51.80 (2000503603)
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69924-9 (42868415)
Type 1 diabetes mellitus, With multiple complications
E10.7 (45571655)
Other and unspecified skin changes
R23.8 (45573020)
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
69926-4 (42868417)
Observation for other suspected diseases and conditions
Z03.8 (45585798)
Rash localized
S06 (2002000971)
Supplier / Service Provider
OMOP5117446 (33004)
Intravenous administration of medicine
SPAT1255 (2001700356)
Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
49615-8 (3030429)
Case Management Agency
251B00000X (38004193)
Administration of medicine
SPAT1254 (2001700355)
Home Visit
OMOP4822459 (581476)
Rash and other nonspecific skin eruption
R21 (45553721)
memantine; oral
N06DX01 (21604799)
Bacteria identified in Cerebral spinal fluid by Culture
606-4 (3016914)
fluconazole; oral, parenteral
J02AC01 (21603080)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
Pain in joint
M25.5 (45586941)
Skin colour change
S08 (2002000973)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
Pharmacy visit
OMOP4822462 (581458)
Support of social functional capacity
SPAT1234 (2001700335)
insulin detemir; parenteral
A10AE05 (21600740)
Paraesthesia of skin
R20.2 (45568120)
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 (3021614)
Emergency Room Visit
ER (9203)
insulin aspart; parenteral
A10AB05 (21600719)
insulin aspart; parenteral
A10AD05 (21600733)
Tension-type headache
G44.2 (45581495)
desonide
D07AB08 (21602112)
Nuclear Ab [Presence] in Serum
8061-4 (3004616)
Arthritis, unspecified
M13.9 (45567463)
Generalized skin eruption due to drugs and medicaments
L27.0 (45538572)
General and Unspecified, Preventive immunization/medic
A44 (2002000178)
Consultation of another employee
SPAT1260 (2001700361)
Internal Medicine
11 (38004456)
Observation for other suspected diseases and conditions
Z03.89 (2000503757)
hydrocortisone
S02BA01 (21605166)
insulin lispro; parenteral
A10AD04 (21600732)
Type 1 diabetes mellitus, Without complications
E10.9 (45581351)
fusidic acid; ointment
D06AX01 (21602062)
fusidic acid
D09AA02 (21602265)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
Atherosclerosis of arteries of extremities
I70.2 (45538421)
insulin lispro; parenteral
A10AB04 (21600718)
insulin lispro; parenteral
A10AC04 (21600726)
C reactive protein [Mass/volume] in Body fluid
16503-5 (3035320)
Office Visit
OMOP4822458 (581477)
Nitrate [Presence] in Urine
32030-9 (3006462)
Microorganisms panel - Urine sediment
58435-9 (40761536)
Nursing episode
950 (44777714)
olanzapine; oral, parenteral
N05AH03 (21604543)
Observation for suspected nervous system disorder
Z03.3 (45609903)
hydrocortisone
D07AA02 (21602102)
hydrocortisone butyrate
D07AB02 (21602106)
hydrocortisone buteprate
D07AB11 (21602115)
hydrocortisone aceponate
D07AC16 (21602135)
hydrocortisone
A07EA02 (21600654)
hydrocortisone
C05AA01 (21601608)
Allergic urticaria
L50.0 (45581945)
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 (3041942)
azithromycin; oral, parenteral
J01FA10 (21602978)
Counselling/guidance promoting independent living
SPAT1222 (2001700323)
Urine protein measurement
57378007 (4211845)
Lactate [Moles/volume] in Blood
32693-4 (3047181)
insulin (beef); parenteral
A10AD02 (21600730)
insulin glargine; parenteral
A10AE04 (21600739)
Inpatient Hospital
21 (8717)
Bacterial infection, unspecified
A49.9 (45590816)
Heart failure, unspecified
I50.9 (45576879)
In Home Supportive Care Agency
253Z00000X (38004206)
combinations of corticosteroids
D07AB30 (21602118)
combinations of corticosteroids
D07XB30 (21602188)
General Practice
1 (38004446)
Outpatient Hospital
22 (8756)
donepezil; oral
N06DA02 (21604795)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
mometasone
D07AC13 (21602132)
C reactive protein [Mass/volume] in Blood by High sensitivity method
71426-1 (42870365)
Actinic keratosis
L57.0 (45591640)
ECG with 12 standard connections
XF400 (2001303368)
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 (3008733)
imidazoles/triazoles in combination with corticosteroids
D01AC20 (21601936)
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 (3016881)
Counselling related to known health issue
SPAT1310 (2001700411)
Person consulting for explanation of investigation findings
Z71.2 (45552100)
Erysipelas
A46 (45561706)
Outpatient Visit
OP (9202)
Local infection of skin and subcutaneous tissue, unspecified
L08.9 (45577027)
insulin degludec; parenteral
A10AE06 (43534747)
Skin Pathology biopsy report
65754-4 (40768443)
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 (45552380)
General health counselling
SPAT1312 (2001700413)
Inpatient Visit
IP (9201)
Intravenous
ZX120 (2001311495)
Rheumatology
66 (38004491)
Type 2 diabetes mellitus, with unspecified complications
E11.8 (45561951)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
Handing over of treatment supplies
SPAT1262 (2001700363)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
pH of Specimen
17433-4 (3019225)
Other specified chronic obstructive pulmonary disease
J44.8 (45586673)
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 (3049804)
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 (2001700354)
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 (3023081)
Dizziness and giddiness
R42 (45568132)
Examination and observation for other specified reasons
Z04.8 (45552063)
Treatment of chronic ulcer or burn
SPAT1148 (2001700249)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
hydrocortisone; local oral
A01AC03 (21600036)
Urticaria, unspecified
L50.9 (45562541)
hydrocortisone and antiseptics
D07BA04 (21602146)
hydrocortisone
D07XA01 (21602180)
Emergency Medicine
93 (38004510)
triamcinolone and antiseptics
D07BB03 (21602150)
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 (21604305)
other antifungals for topical use - combinations; ointment
D01AE20 (21601959)
chlorhexidine, combinations
D08AC52 (21602208)
chlorhexidine
D09AA12 (21602275)
chlorhexidine
S02AA09 (21605155)
chlorhexidine
S03AA04 (21605193)
saccharomyces boulardii; oral
A07FA02 (21600670)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
Malaise and fatigue
R53 (45553741)
Initiation and monitoring of IV fluid therapy
SPAT1083 (2001700184)
pH of Blood
11558-4 (3010421)
Telehealth
OMOP5556618 (722455)
Oxygen [Partial pressure] in Capillary blood
2704-5 (3028626)
Cathetrisation of vein
TPH04 (2001309597)
Emergency Room and Inpatient Visit
ERIP (262)
Guidance concerning treatment of rash and skin
SPAT1156 (2001700257)
Oxygen [Partial pressure] in Blood
11556-8 (3027315)
Phadiatop IgE Ab [Units/volume] in Serum
7599-4 (3025443)
Oxygen saturation in Arterial blood
2708-6 (3016502)
Carbon dioxide [Partial pressure] in Blood
11557-6 (3013290)
Base excess in Blood by calculation
11555-0 (3012501)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
Lactate [Moles/volume] in Venous blood
2519-7 (3008037)
Thorax X-ray examination
GD1AA (2001303617)
Base excess in Arterial blood by calculation
1925-7 (3003396)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
Sampling
SPAT1263 (2001700364)
Cholesterol non HDL [Moles/volume] in Serum or Plasma
70204-3 (42868678)
Assessment of need for services (elderly/care support)
SPAT1217 (2001700318)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
Methemoglobin/Hemoglobin.total in Blood
2614-6 (3007930)
pH of Arterial blood
2744-1 (3019977)
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 (3006999)
furosemide; oral, parenteral
C03CA01 (21601518)
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 (3016921)
Bacteria identified in Blood by Culture
600-7 (3023368)
Glucose [Moles/volume] in Venous blood
39480-9 (3038515)
Counselling and guidance which enhance independent living
R2130 (2001310196)
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 (3045783)
Otolaryngology
4 (38004449)
Tissue Pathology biopsy report
66121-5 (40768804)
lactulose; oral
A06AD11 (21600571)
Other specified counselling
Z71.8 (45581061)
desloratadine; oral
R06AX27 (21603526)
Own respiration
WX720 (2001310823)
More than one and less than three hours
ZXE10 (2001311401)
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 (3009035)
Hand/finger symptom/complaint
L12 (2002000636)
Pure hypercholesterolaemia
E78.0 (45542771)
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 (3027450)
buprenorphine; parenteral, sublingual, transdermal
N02AE01 (21604287)
Acute bronchitis, unspecified
J20.9 (45562445)
Skin texture symptom/complaint
S21 (2002000986)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
Counselling and guidance related to nutrition and weight management
SPAT1306 (2001700407)
One hour or less
ZXE00 (2001311394)
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 (45587505)
Gonarthrosis [arthrosis of knee]
M17 (45601350)
Foot/toe symptom/complaint
L17 (2002000641)
Risk factor NOS
A23 (2002000158)
Physiotherapy
R4110 (2001310233)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
Acute maxillary sinusitis
J01.0 (45601112)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
betamethasone
A07EA04 (21600656)
betamethasone
C05AA05 (21601610)
betamethasone
D07AC01 (21602120)
betamethasone
S02BA07 (21605169)
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11054-4 (3002109)
Pain/tenderness of skin
S01 (2002000966)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
Pain in limb
M79.6 (45587063)
insulin (human); parenteral
A10AD01 (21600729)
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 (3036086)
Bicarbonate [Moles/volume] in Venous blood
14627-4 (3027273)
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 (3034780)
cetirizine; oral
R06AE07 (21603497)
Differential panel, method unspecified - Blood
69738-3 (42870588)
sitagliptin; oral
A10BH01 (21600784)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
spironolactone; oral
C03DA01 (21601534)
Physiotherapist
Z3226 (2001311560)
Observation for suspected disease or condition, unspecified
Z03.9 (45552062)
Chest pain, unspecified
R07.4 (45558450)
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 (42868674)
Aid fitting and borrowing and monitoring of use
SPAT1230 (2001700331)
empagliflozin; oral
A10BK03 (1123740)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
Bacteria [#/volume] in Urine by Culture
100906-7 (1761482)
Osmolality of Urine
2695-5 (3026782)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
dexamethasone and antiinfectives
S03CA01 (21605206)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
Bacteria identified in Urine by Culture
630-4 (3026008)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Basophils/Leukocytes in Blood
30180-4 (3022096)
C reactive protein [Mass/volume] in Capillary blood
48421-2 (3051387)
Laboratory test
15220000 (4034850)
Comprehensive monitoring of chronic illness
SPAT1250 (2001700351)
Hyperplasia of prostate
N40 (45563015)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
hydroxyzine; oral, parenteral
N05BB01 (21604590)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Basophils [#/volume] in Blood
26444-0 (3006315)
Headache
N01 (2002000720)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Chloride [Moles/volume] in Blood
2069-3 (3018572)
Anion gap in Blood by calculation
41276-7 (3039000)
Disease/condition unspecnature/site
A99 (2002000232)
Short blood count panel - Blood
55429-5 (40758558)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
epinephrine; parenteral
C01CA24 (21600303)
epinephrine
S01EA01 (21603673)
Estimation of glomerular filtration rate
791801000000102 (44806420)
other preparations, combinations; ointment
C05AX03 (21601631)
naproxen; oral, rectal
M01AE02 (21603968)
naproxcinod
M01AE18 (40254094)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
quetiapine; oral
N05AH04 (21604544)
Blasts/Leukocytes in Blood
26446-5 (3025159)
oxycodone; oral, parenteral
N02AA05 (21604260)
Other and unspecified abdominal pain
R10.4 (45568113)
dapagliflozin; oral
A10BK01 (1123890)
Standard MRI examination of brain with high intensity magnet
AA1BG (2001300112)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Other minor procedure on skin
TQW99 (2001310150)
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 (2001700321)
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 (3005013)
naproxen and esomeprazole; oral
M01AE52 (40254096)
zoster, purified antigen
J07BK03 (1501889)
Melanocytic naevi
D22 (45595739)
Granulocytes [#/volume] in Blood
30394-1 (3035715)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
chloramphenicol
S01AA01 (21603554)
chloramphenicol
S03AA08 (21605197)
fluticasone, combinations
R01AD58 (43534837)
azelastine; nasal
R01AC03 (21605035)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
No procedures
SPAT1301 (2001700402)
Gas panel - Arterial blood
24336-0 (3019060)
metoprolol; oral, parenteral
C07AB02 (21601684)
Acute upper respiratory infection, unspecified
J06.9 (45562437)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Treatment-related counselling outside office
SPAT1249 (2001700350)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
metformin; oral
A10BA02 (21600747)
fluticasone; nasal
R01AD08 (21605050)
fluticasone furoate; nasal
R01AD12 (21605053)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
hydrocortisone; oral, parenteral
H02AB09 (21602737)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
isosorbide mononitrate; oral
C01DA14 (21600324)
Other seropositive rheumatoid arthritis
M05.8 (45538634)
Skin infection other
S76 (2002001040)
General and Unspecified, Medication/prescr/renewal
A50 (2002000184)
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 (3011960)
pseudoephedrine, combinations; oral
R01BA52 (21603213)
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 (21604376)
prednisolone
A07EA01 (21600653)
prednisolone; oral, parenteral
H02AB06 (21602734)
Type 2 diabetes mellitus
E11 (45571656)
Intubation
WX704 (2001310820)
Hypersensitivity skin testing
268377001 (4147813)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
Atherosclerotic heart disease
I25.1 (45596196)
etoricoxib; oral
M01AH05 (21603996)
Low back pain
M54.5 (45553207)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Supine thorax X-ray examination
GD1QA (2001303648)
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 (3004529)
Need for immunization against other specified single viral diseases
Z25.8 (45547296)
cromoglicic acid
S01GX01 (21605085)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
ibuprofen
R02AX02 (1588667)
ibuprofen; oral, parenteral, rectal
M01AE01 (21603967)
Health maint/preventive medicine
A98 (2002000231)
Lumbar spine X-ray examination with flexion
NA3EA (2001307044)
Hypothyroidism, unspecified
E03.9 (45537945)
Specific gravity of Urine by Refractometry
5810-7 (3019150)
dexamethasone
S03BA01 (21605201)
dexamethasone
S01BA01 (21603618)
Knee symptom/complaint
L15 (2002000639)
cefalexin; oral
J01DB01 (21602870)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
acrivastine; oral
R06AX18 (21603518)
Laboratory Visit
OMOP4822461 (32036)
acetylsalicylic acid; oral
B01AC06 (21600991)
Localized swelling, mass and lump, unspecified
R22.9 (45577788)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
losartan and diuretics
C09DA01 (21601834)
Oncology Clinic/Center
261QX0200X (38004268)
imiquimod
D06BB10 (21602092)
Examination for driving licence
Z02.4 (45552056)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
Need for immunization against influenza
Z25.1 (45581017)
Gynecological ultrasound examination as part of clinical examination
LX1AE (2001306815)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
Arthrocentesis, unspecified region, unspecified region
TNX10 (2001308560)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
ramipril; oral
C09AA05 (21601789)
Sedation and analgesia
WX002 (2001310758)
diclofenac; oral, parenteral, rectal
M01AB05 (21603945)
EKG study
11524-6 (3013512)
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 (21602517)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
prednisolone
S01BA04 (21603621)
prednisolone
S03BA02 (21605202)
Tinnitus
H93.1 (45543152)
Lipid panel - Serum or Plasma
100898-6 (1761868)
Periodontal treatment by dental hygienist, extensive
SDE03 (2001310351)
amlodipine; oral
C08CA01 (21601747)
ispaghula (psylla seeds); oral
A06AC01 (21600555)
Seborrhoeic keratosis
L82 (45548208)
Scheduled procedure
ZXD10 (2001311387)
Audiometric test
21727005 (4071702)
Pure hypercholesterolaemia
E78.01 (2000501514)
Essential (primary) hypertension
I10 (45591453)
INR in Blood by Coagulation assay
34714-6 (3032080)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
Normoblasts [#/volume] in Blood
715-3 (3021589)
ezetimibe; oral
C10AX09 (21601896)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Platelets [#/volume] in Blood
26515-7 (3007461)
Endocrinology
46 (38004485)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
MCH [Entitic mass]
28539-5 (3035941)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Sleep apnoea
G47.3 (45562094)
tizanidine; oral
M03BX02 (21604116)
bisoprolol; oral
C07AB07 (21601689)
candesartan; oral
C09CA06 (21601829)
Joint ultrasound examination not elsewhere classified
NK4XE (2001308469)
tetanus toxoid, combinations with diphtheria toxoid
J07AM51 (21601317)
Extensive high resolution CT examination of lungs
GD1ED (2001303637)
Pain localized to other parts of lower abdomen
R10.3 (45534426)
Diabetes non-insulin dependent
T90 (2002001131)
Hemoglobin [Presence] in Urine by Test strip
5794-3 (3011397)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
pantoprazole; oral, parenteral
A02BC02 (21600097)
General anesthesia, balanced
WX408 (2001310808)
amitriptyline; oral, parenteral
N06AA09 (21604696)
influenza, inactivated, split virus or surface antigen
J07BB02 (21601335)